Dose finding study of bryostatin-1 and GM-CSF in refractory myeloid malignancies
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bryostatin-1 (Primary) ; Sargramostim
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Chronic myelomonocytic leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 09 Jan 2013 Biomarkers information updated
- 02 Feb 2010 Actual end date (Jan 2010) added as reported by ClinicalTrials.gov.
- 02 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.